(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)hex-5-enoic acid, 95.0%, 1g

Ethyl 2,3-dichloroisonicotinate, 97%, 1g

CEFOSELIS SULFATE, 98%, 50mg

1,2,3,6-Tetrahydropyridine-4-carbonitrile hydrochloride, 95%, 50mg

2,5-Dimethoxybenzaldehyde, 97.0%, 25g

(5-methyl-1H-pyrazol-4-yl)boronic acid, 98%, 1g

(2R,5S)-2,5-Dimethyl-1-(phenylmethyl)piperazine, 98%, 5g

Éther monobutylique de propylèneglycol, min 99%, pour la synthèse, 5 l, emballage plastique.

(2E)-1-(4-ethylphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

Ethyl 7-Chloroimidazo[1,2-a]pyridine-2-carboxylate, 97.0%, 250mg

Thieno[2,3-c]pyridin-7(6H)-one, 95.0%, 1g

N4-(Benzo[d][1,3]dioxol-5-ylmethyl)-6-(3-methoxyphenyl)pyrimidine-2,4-diamine, 95.0%, 100mg

2-(1-(Boc)-3,3-difluoropiperidin-4-yl)acetic acid, 98%, 250mg